- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
PAREXEL's Inaugural Podcast Focuses on International Women's Day
PAREXEL, the global provider of biopharmaceutical services, has today published its inaugural podcast with International Women’s Day as the focus. Hosted by Harvard Kennedy School expert Siri Chilazi, the podcast features the advice and expertise of some of PAREXEL’s most remarkable women in STEM.
Commenting on this year’s campaign theme, Ubavka DeNoble M.D., Corporate Vice President, Patient Technology, PAREXEL, said: “We now talk about a balanced boardroom, a balanced government, a balanced media approach. 15 years ago, that was a strange topic. There has been huge progress. We must remember that (any imbalance) is humanity’s issue and the only one way to resolve it is to work together: males and females.”
To listen to the full podcast – which features discussion around International Women’s Day from Ubavka DeNoble M.D. – Corporate Vice President of Patient Technology, Kemi Olugemo – Senior Director, Global Therapeutic Area Head, Aida Sabo – VP Diversity, and Peyton Howell – Chief Commercial and Strategy Officer – please click here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
